Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | IVS-3001 |
Trade Name | |
Synonyms | IVS 3001|IVS3001 |
Drug Descriptions |
IVS-3001 are autologous T-lymphocytes engineered to express a chimeric antigen receptor (CAR) targeting HLA-G, which potentially enhance antitumor immune response (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C192117 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
IVS-3001 | IVS-3001 | 0 | 1 |